CE Mark Study for the Harpoon Medical Device
Mitral TRans-Apical neoChordal Echo-guided Repair (TRACER) Trial
Sponsor: Edwards Lifesciences
Listed as NCT02768870, this NA trial focuses on Mitral Valve Insufficiency and Mitral Valve Prolapse and remains completed. Sponsored by Edwards Lifesciences, it has been updated 17 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2024 — Jul 2024 [monthly]
Completed NA
-
May 2023 — Feb 2024 [monthly]
Completed NA
▶ Show 12 earlier versions
-
Jan 2023 — May 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2022 — Jan 2023 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Mar 2022 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Dec 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Aug 2019 — Dec 2019 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Aug 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2017 — Dec 2017 [monthly]
Recruiting NA
Status: Withheld → Recruiting
-
Feb 2017 — Oct 2017 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • London, United Kingdom
- • Milan, Italy
- • Padua, Italy
- • Southampton, United Kingdom